A recent study examined the potential association between psoriasis and depression, and whether the risk of depression increased with psoriasis severity.
In a recent study, interclass switching of biologic agents in psoriasis was associated with faster and more durable disease control, particularly when transitioning to anti–IL-23p19 therapies. However, the...